SCHEMBL18565121

SCHEMBL18565121

c1ccc(N(c2ccccc2)c2ccc3c4ccccc4n(-c4nc(N(c5ccccc5)c5ccc6c(c5)c5ccccc5n6-c5ccccc5)nc(-n5c6ccccc6c6ccc(N(c7ccccc7)c7ccccc7)cc65)n4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
XBP1 P17861 1/20 0.38
NTSR1 P30989 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 3/20 0.37
ALDH1A1 P00352 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
TP53 P04637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PKM P14618 1/20 0.32
CTSK P43235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565188 1.00 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565122 1.00 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565127 1.00 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565192 0.98 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565131 0.98 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565128 0.98 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565162 0.98 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565165 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565163 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMMAPTSMN1; SMN2
SCHEMBL18565126 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.